State Street Corp Kiniksa Pharmaceuticals, Ltd. Call Options Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KNSA
# of Institutions
164Shares Held
40.6MCall Options Held
186KPut Options Held
157K-
Black Rock Inc. New York, NY4.19MShares$81.2 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.2MShares$62 Million10.07% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E93.14MShares$60.7 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.98MShares$57.7 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.81MShares$54.4 Million0.7% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $667M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...